Future Prescriber
Future Prescriber provides information on new drugs from early development through to launch. It also covers significant developments with drugs that are currently available and discusses the potential impact of prescribing policy changes. Future Prescriber is designed for decision makers in Trusts and Strategic Health Authorities and also lead-prescribing members of PCTs, LHCCs and LHGs. Future Prescriber meets the growing information needs of decision makers and planners in the NHS and ensures that these decision makers are well informed and prepared for the changes brought about by important new product initiatives. Access to all content is free to healthcare professionals following registration.
Current Issue
- Asenapine: novel antipsychotic for treatment of bipolar I disorder
- Published online on Jan 03, 2012
- Immunotherapy for treatment of advanced prostate cancer
- Published online on Jan 03, 2012
- Dapagliflozin: a new possibility for managing type 2 diabetes
- Published online on Jan 03, 2012
- Promising developments in the treatment of cancer
- Published online on Jan 03, 2012
Latest News
- Ezetimibe/simvastatin cuts cardiovascular events in CKD
- Published on Aug 08, 2011
Treatment with ezetimibe plus simvastatin (Inegy) significantly reduced major atherosclerotic events in patients with chronic kidney disease (CKD),...
- Funding for tailored cancer treatment
- Published on Aug 08, 2011
The Technology Strategy Board has announced Government funding totalling £6 million to support research into tumour profiling and data capture...
- Once-weekly exenatide approved
- Published on Aug 08, 2011
Bydureon, an extended-release formulation of exenatide 2mg, has received marketing approval in the EU, making it the first once-weekly GLP-1 agonist...
